Researchers identify stem cell–based molecular subtypes that improve prognosis prediction in colorectal cancer and support ...

Final results from the phase 3 CASSANDRA trial presented at the 2025 ASCO Meeting show that the neoadjuvant chemotherapy ...

Patients with stage 3 colorectal cancer who tested MRD-positive with Signatera after surgery saw a meaningful survival ...

The findings are particularly relevant for India, where colorectal cancer is emerging as a growing public health concern ...

Colon Cancer, also referred to as “colorectal” cancer, still ranks among the major challenges to humanity because it affects ...

New clinical evidence indicates that a widely used supplement may alter gut microbes involved in vitamin D biology and ...

In most solid tumors, high numbers of regulatory T (Treg) cells are associated with poorer outcomes because they dampen the ...

In low-resource regions such as Nigeria, most people with colorectal cancer are diagnosed too late for curative treatment ...

Colorectal cancer — which includes cancer of the colon and of the rectum — is considered early onset when diagnosed in people ...

In locally recurrent rectal cancer, neoadjuvant chemo-reirradiation plus surgery with IOERT showed no grade 4–5 toxicities ...

She was shocked to be diagnosed with rectal cancer at 29 and had her reproductive organs temporarily moved out of her pelvis to be able to become pregnant after treatment.

CNW/ - Takeda Canada Inc. ("Takeda") is pleased to announce that FRUZAQLATM (fruquintinib capsules) will now be reimbursed by ...